Status:
COMPLETED
Short Term Growth in Children With Atopic Dermatitis
Lead Sponsor:
Children´s Clinic, Randers
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
5-14 years
Phase:
PHASE4
Brief Summary
Main objective:to assess short term growth in children with atopic dermatitis during treatment with tacrolimus 0.1% and mometasone furoate 0.1%. A singl blind randomised cross over trial including 20 ...
Eligibility Criteria
Inclusion
- age 5-14, atopic dermatitis, normal current growth, Tanner 1, informed consent by the parent or guardian, willing and able to comply with study procedures
Exclusion
- Tanner 2-5, treatment of atopic dermatitis with anti-inflammatory agent within 1 week before the first visit, current asthma or rhinoconjunctivitis that requires treatment with glucocorticoids, endocrine diseases, major surgery within 4 weeks prior to visit 1, fever \>39.5 for \>3 days
Key Trial Info
Start Date :
February 1 2005
Trial Type :
INTERVENTIONAL
End Date :
June 1 2005
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00236106
Start Date
February 1 2005
End Date
June 1 2005
Last Update
December 9 2005
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.